MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales of marketable
securities
$24,294K
Net proceeds from
issuance of common stock
$844K
Proceeds from exercise of
options
$8K
Net cash provided by
investing activities
$15,086K
Net cash provided by
(used in) financing...
$599K
Effect of exchange rate
changes on cash
$11K
Canceled cashflow
$9,208K
Canceled cashflow
$253K
Net decrease in cash
and cash...
-$253K
Canceled cashflow
$15,696K
Share-based compensation
expense
$1,226K
Prepaid and other
current assets
-$742K
Allowance for credit
losses
$500K
Accounts receivable
-$401K
Depreciation and
amortization
$146K
Other assets
-$140K
Impairment of
non-financial asset
$127K
Purchase of marketable
securities
$9,180K
Purchases of property and
equipment
$28K
Tax withholding
payments on net share...
$253K
Net cash used in
operating activities
-$15,949K
Canceled cashflow
$3,282K
Net loss
-$16,586K
Accounts payable,
accrued liabilities and...
-$2,570K
Amortization/accretion on marketable
securities
$75K
Back
Back
Cash Flow
source: myfinsight.com
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)